Abstract:Background: Chronic cyclosporine A (CsA) nephropathy is a well described side effect of CsA treatment. CsA has been shown to induce the synthesis of extracellular matrix (ECM) proteins in mesangial cells (MCs) in vitro, and glomerulosclerosis in vivo. Transforming growth factor-beta1 (TGF-beta1) is a potent stimulus for the synthesis of ECM proteins in MCs. We investigated whether CsA up-regulates the expression of TGF-beta1 and its receptors type I (TbetaR-I) and type II (TbetaR-II) in cultured rat MCs, and whether this effect translates into enhanced matrix protein accumulation. Methods: Resting MCs were incubated in the presence or absence of CsA and anti-TGF-beta1 antibodies. Time- and concentration-dependent expression of TGF-beta1, TbetaR-I and TbetaR-II were measured at both the mRNA (competitive reverse transcription PCR) and protein level (enzyme-linked immunosorbent assay (ELISA) and western blotting). Fibronectin (FN) and plasminogen activator inhibitor type-1 (PAI-1) synthesis were measured by ELISA. Results: Compared with untreated controls, CsA stimulated mRNA production of TGF-beta1 (maximum at 72 h, 500 ng/ml CsA: 2.1+/-0.5-fold, P<0.001) and TbetaR-II (maximum at 72 h, 1000 ng/ml CsA: 2.4+/-0.4-fold, P<0.005) time- and dose-dependently. TbetaR-I mRNA concentrations remained unchanged. Protein concentrations were analysed at 96 h: TGF-beta1, 220+/-32 vs 86+/-24 pg/ml, P<0.001 (500 ng/ml CsA vs control); TbetaR-I, 2.0+/-0.5-fold, P<0.005 (1000 ng/ml CsA vs control); TbetaR-II, 2.5+/-0.7-fold, P<0.05 (1000 ng/ml CsA vs control). CsA (500 ng/ml) also enhanced the production of FN (1.6-fold, P<0.05) and PAI-1 (2.0-fold, P<0.05). Co-incubation with neutralizing anti-TGF-beta1 antibodies reduced (P<0.05) CsA-induced expression of TbetaR-I (1.0+/-0.1-fold), TbetaR-II (1.3+/-0.1-fold) and PAI-1 (1.3-fold), but not FN production (1.6-fold). Conclusions: Pharmacologically relevant concentrations of CsA time- and dose-dependently up-regulate the expression of TGF-beta1 and, via autocrine mechanisms, its receptors type I and II in rat MCs. Whereas up-regulation of PAI-1 is mediated by TGF-beta1, up-regulation of FN is-at least in part-either directly induced by CsA or mediated by factors other than TGF-beta1.

Cyclosporine Stimulates the Renal Epithelial Sodium Channel by Elevating Cholesterol

NaHS or Lovastatin Attenuates Cyclosporine A–Induced Hypertension in Rats by Inhibiting Epithelial Sodium Channels

Activation of Kir4.1/Kir5.1 Contributes to the Cyclosporin A‐induced Stimulation of the Renal NaCl Cotransporter and Hyperkalemic Hypertension

Cyclosporin A Inhibits the Activation of Membrane-Bound Guanylate Cyclase GC-A of Atrial Natriuretic Factor via NAD(P)H Oxidase

[Effects of Cyclosporin A on Gene Expression Profiles of NIT-1 Pancreatic Beta Cell Line].

Cyclosporin A Disrupts Bradykinin Signaling Through Superoxide.

Cyclosporine A protects podocytes via stabilization of cofilin-1 expression in the unphosphorylated state.

Cyclosporine A up-regulates the expression of TGF-beta1 and its receptors type I and type II in rat mesangial cells

Expression of Angiotensin II and Its Receptors in a Rat Model of Chronic Cyclosporine Nephrotoxicity

Mechanism of Cyclosporine A Nephrotoxicity: Oxidative Stress, Autophagy, and Signalings.

Cyclosporine A Protects Podocytes by Regulating Transgelin in Adriamycin-Induced Podocyte Injury

Role of endothelium derived relaxing factor in cyclosporine A induced nephrotoxicity

Role of (pro)renin receptor in cyclosporin A-induced nephropathy

Expression of Erythropoietin and Its Receptor in Kidneys from Normal and Cyclosporine-Treated Rats.

Different effects of CsA and FK506 on aquaporin-2 abundance in rat primary cultured collecting duct cells

Long-term Treatment with Cyclosporine Decreases Aquaporins and Urea Transporters in the Rat Kidney.

Effect of cyclosporin A on the biliary excretion of cholephilic compounds in rats

Cyclosporine-A induced cytotoxicity within HepG2 cells by inhibiting PXR mediated CYP3A4/CYP3A5/MRP2 pathway

Cyclosporin A Enhances the Calcium-Dependent Induction of AP-1 Complex and C-Fos Mrna in a T Cell Lymphoma.

Interference of cyclosporine on glucose metabolism: potential role in chronic transplantation kidney fibrosis.

Vasomotor Dysfunction in the Mesenteric Artery after Organ Culture with Cyclosporin A.